We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Comparison of Neoadjuvant Chemotherapy Plus Interval Debulking Surgery and Primary Debulking Surgery in Patients with Stage III and IV Ovarian Carcinoma: A Multicenter Real Life Experience.
- Authors
YILMAZ, Mukaddes; BAŞAK, Mustafa; TATAROĞLU ÖZYÜKSELER, Deniz; YILDIRIM, Mahmut Emre; ARIK, Zafer; SALMAN, Mehmet Coşkun; GÜLTEKIN, Murat; AKGÖR, Utku; KURT İNCI, Bediz; GÜRLER, Fatih; BIR YÜCEL, Kadriye; ŞAVAŞ, Gözde; ONAN, Mehmet Anıl; SUNAR, Veli; MEYDANLI, Mehmet Mutlu; YAZICI, Ozan; ÖZET, Ahmet
- Abstract
OBJECTIVE The aim of the study is to compare treatment outcomes of the patients with federation of gynecology and obstetrics stages III and IV ovarian carcinomas, who underwent interval debulking surgery after neoadjuvant chemotherapy (NACT), and patients who underwent adjuvant chemotherapy after primary debulking surgery (PDS). METHODS Patients from four centers (n=183) were retrospectively evaluated. Of the patients, 91 (50%) were in the PDS group and 92 (50%) in the NACT group. RESULTS In the NACT group patients have advanced age, poor performance status, high levels of CA125, and advanced disease stage compared with the PDS group (p<0.050). Of the patients receiving NACT, 14 (15%) had a complete response, and 68 (74%) had a partial response. The R0 rate was higher in the PDS group (p=0.018). In univariate analysis, poor prognostic factors affecting OS were NACT in the treatment protocol (p<0.001), poor performance status (p<0.001), advanced age (<70 vs. =70, p=0.002), advanced clinical stage (p=0.042), and localization of the tumor with the largest diameter outside the omentum and ovary at the time of diagnosis (p=0.029). In the multivariate analysis, the presence of NACT (HR: 2.30, 95% CI: 1.25-4.23, p=0.007) and poor performance (HR: 2.52, 95% CI: 1.18-5.10, p=0.017) were independent poor prognostic factors for OS. CONCLUSION In the study, OS was better in the PDS group than in the NACT group. This result was thought to be associated with the NACT group having more disadvantageous characteristics (advanced age, poor performance, high CA125 level, advanced stage, etc.).
- Subjects
RESEARCH; STATISTICS; OVARIAN tumors; CONFIDENCE intervals; CANCER chemotherapy; MULTIVARIATE analysis; RETROSPECTIVE studies; TUMOR classification; EXPERIENCE; TREATMENT effectiveness; COMPARATIVE studies; DESCRIPTIVE statistics; COMBINED modality therapy; CYTOREDUCTIVE surgery
- Publication
Turkish Journal of Oncology / Türk Onkoloji Dergisi, 2023, Vol 38, Issue 3, p323
- ISSN
1300-7467
- Publication type
Article
- DOI
10.5505/tjo.2023.3883